The discovery that CD137 is expressed by most of activated and antigen-specific (both against viral and tumor antigens) CD8+ T-cells, allowed the isolation of tumor-specific effector T-cells from blood, without knowing the immunogenic epitopes or the MHC-restriction complex. The gene discussed is HLA-C; the disease is neoplasm.